By Abigail Townsend
Date: Thursday 29 Jan 2026
(Sharecast News) - AstraZeneca is to invest $15bn in China by the end of the decade, the UK drugs giant confirmed on Thursday, as part of the prime minister's visit to the country.
The Cambridge-based blue chip plans to develop its existing manufacturing facilities in Wuxi, Taizhou, Qingdao and Beijing, as...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news